Publications by authors named "Doris R Siwak"

21Publications

Analytical Platforms 3: Processing Samples via the RPPA Pipeline to Generate Large-Scale Data for Clinical Studies.

Adv Exp Med Biol 2019 ;1188:113-147

Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-981-32-9755-5_7DOI Listing
December 2019

Suppression of Nuclear Factor-κB by Glucocorticoid Receptor Blocks Estrogen-Induced Apoptosis in Estrogen-Deprived Breast Cancer Cells.

Mol Cancer Ther 2019 10 11;18(10):1684-1695. Epub 2019 Sep 11.

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-18-1363DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6774891PMC
October 2019

Development of a robust classifier for quality control of reverse-phase protein arrays.

Bioinformatics 2015 Mar 6;31(6):912-8. Epub 2014 Nov 6.

Department of Bioinformatics and Computational Biology, Department of Systems Biology and Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/bioinformatics/btu736DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4375399PMC
March 2015

Targeting the epidermal growth factor receptor in epithelial ovarian cancer: current knowledge and future challenges.

J Oncol 2010 19;2010:568938. Epub 2009 Nov 19.

Department of Systems Biology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://www.hindawi.com/journals/jo/2010/568938/
Publisher Site
http://dx.doi.org/10.1155/2010/568938DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2796463PMC
July 2011

Cetuximab attenuates metastasis and u-PAR expression in non-small cell lung cancer: u-PAR and E-cadherin are novel biomarkers of cetuximab sensitivity.

Cancer Res 2009 Mar 10;69(6):2461-70. Epub 2009 Mar 10.

Department of Experimental Surgery and Molecular Oncology of Solid Tumors, Medical Faculty Mannheim, University Heidelberg and DKFZ (German Cancer Research Center), Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-08-3236DOI Listing
March 2009

Telomere 3' overhang-specific DNA oligonucleotides induce autophagy in malignant glioma cells.

FASEB J 2007 Sep 20;21(11):2918-30. Epub 2007 Apr 20.

Department of Neurosurgery, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1096/fj.06-6941comDOI Listing
September 2007

KGF-induced motility of breast cancer cells is dependent on Grb2 and Erk1,2.

Clin Exp Metastasis 2004 ;21(5):437-43

Department of Pharmaceutical Sciences, University of Oklahoma, Health Sciences Center, Oklahoma City, Oklahoma 73117, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007/s10585-004-2051
Web Search
http://dx.doi.org/10.1007/s10585-004-2051-8DOI Listing
March 2005

The HER2/Grb2/Akt pathway regulates the DNA binding activity of AP-1 in breast cancer cells.

Oncol Rep 2004 Oct;12(4):903-8

Department of Bioimmunotherapy, Section of Immunobiology and Drug Carriers, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
October 2004

Liposomal antisense oligonucleotides for cancer therapy.

Methods Enzymol 2004 ;387:241-53

Department of Bioimmunotherapy, The University of Texas M D Anderson Cancer Center, Houston, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0076-6879(04)87015-0DOI Listing
July 2004

HER2/neu uses Akt to suppress retinoic acid response element binding activity in MDA-MB-453 breast cancer cells.

Int J Oncol 2003 Dec;23(6):1739-45

Department of Bioimmunotherapy, Section of Immunobiology and Drug Carriers, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
December 2003

Src activation regulates anoikis in human colon tumor cell lines.

Oncogene 2002 Nov;21(51):7797-807

Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, Texas, TX 77030, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/1205989
Publisher Site
http://dx.doi.org/10.1038/sj.onc.1205989DOI Listing
November 2002

The potential of drug-carrying immunoliposomes as anticancer agents. Commentary re: J. W. Park et al., Anti-HER2 immunoliposomes: enhanced efficacy due to targeted delivery. Clin. Cancer Res., 8: 1172-1181, 2002.

Clin Cancer Res 2002 Apr;8(4):955-6

Department of Bioimmunotherapy, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
April 2002